Risperidone and obsessive-compulsive symptoms.
Remington
G
G
Adams
M
M
D014150:Antipsychotic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001714:Bipolar Disorder / Q000188:drug therapy* / Q000523:psychology; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D004409:Dyskinesia, Drug-Induced / Q000188:drug therapy* / Q000209:etiology; D006801:Humans; D007555:Isoxazoles / Q000009:adverse effects* / Q000627:therapeutic use; D016651:Lithium Carbonate / Q000009:adverse effects* / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D009460:Neurologic Examination / Q000187:drug effects; D009771:Obsessive-Compulsive Disorder / Q000139:chemically induced* / Q000523:psychology; D010868:Pimozide / Q000009:adverse effects* / Q000627:therapeutic use; D010880:Piperidines / Q000009:adverse effects* / Q000627:therapeutic use; D012008:Recurrence; D018967:Risperidone
D014150:Antipsychotic Agents; D007555:Isoxazoles; D010880:Piperidines; D010868:Pimozide; D016651:Lithium Carbonate; D018967:Risperidone